U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780318) titled 'A Study of BL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors' on Aug. 19.
Brief Summary: This Phase Ib/II study is a clinical trial exploring the efficacy and safety of BL-M08D1 for injection in patients with locally advanced or metastatic digestive tract tumors and other solid tumors.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Digestive Tract Tumors
Solid Tumors
Intervention:
DRUG: BL-M08D1
Administration by intravenous infusion for a cycle of 3 weeks.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Disclaim...